my case.02
DESCRIPTION
By AbdelMumainTRANSCRIPT
ABDULMUNIM AL ABDULMUNIM AL FARSIFARSI
I CAN NOT HOLD A GLASS
CASE CASE PRESENTATIONPRESENTATIONCMECME
JULY. 13JULY. 13thth , , 20102010
CASE SCENARIO CASE SCENARIO
DIFFERENTIAL DIAGNOSIS ?DIFFERENTIAL DIAGNOSIS ?
MANAGEMENTMANAGEMENT
PITFALLSPITFALLS
TAKE HOME MASSAGETAKE HOME MASSAGE
OBJECTIVESOBJECTIVES OUTLINE OUTLINE
10.07.201010.07.2010
60+ yrs old gentleman .. presented with h/o 60+ yrs old gentleman .. presented with h/o tremortremor in his hands for > 1 month, associated in his hands for > 1 month, associated with slurred speech with slurred speech
CASE CASE SCENARIO SCENARIO
TRIAGE TRIAGE
AAirway: Patentirway: Patent
BBreathing: [spontaneous, RR:16/min, SPO2:99 reathing: [spontaneous, RR:16/min, SPO2:99 % in RA]% in RA]
CCirculation: [BP: 108/66 mmhg, P: 86/min, irculation: [BP: 108/66 mmhg, P: 86/min, regular] regular]
DDisability: [GCS:15 , reflo: 10.7 mmol, T: 37C]isability: [GCS:15 , reflo: 10.7 mmol, T: 37C]
EExposure: NADxposure: NAD
CASE CASE SCENARIO SCENARIO
PRIMARY PRIMARY SURVEYSURVEY
CASE CASE SCENARIO SCENARIO
HISTORYHISTORY
The pt was seen in LHC for this tremor The pt was seen in LHC for this tremor .. Told to have .. Told to have Parkinson disease Parkinson disease
Known to have Known to have - DM type II on insulin- DM type II on insulin- HTN on medication - HTN on medication - LV systolic dysfunction , EF=35%- LV systolic dysfunction , EF=35%- Mild renal impairment - Mild renal impairment - Known psychiatric problem .. f/u in Ibn Sina - Known psychiatric problem .. f/u in Ibn Sina hospitalhospital
CASE CASE SCENARIO SCENARIO
HISTORY HISTORY
No h/o trauma, headache or blurred visionNo h/o trauma, headache or blurred visionNo h/o vomiting or feverNo h/o vomiting or fever
Ex-smoking, No alcohol consumption, No h/o Ex-smoking, No alcohol consumption, No h/o drug abusedrug abuse
h/o incoherent speech, and sleepiness h/o incoherent speech, and sleepiness No h/o chest pain , no SOB, No h/o chest pain , no SOB, No bowel or urine compliantNo bowel or urine compliant
CVSCVS: s1, s2, no murmur, no carotid bruits: s1, s2, no murmur, no carotid bruits
CHESTCHEST: b/l basal minimal: b/l basal minimal
ABDOMENABDOMEN: soft, non tender. no organomegaly: soft, non tender. no organomegaly
CASE CASE SCENARIO SCENARIO
SECONDARY SECONDARY SURVEY SURVEY
CNSCNS::No meningeal signNo meningeal signAlert , oriented to time place and personAlert , oriented to time place and personLt eye cataract . Rt eye pupil reacting to Lt eye cataract . Rt eye pupil reacting to light , no nystagmuslight , no nystagmusfacial asymmetry Rt angle mouth drop facial asymmetry Rt angle mouth drop
UL: Tone: cogwheel rigidity, Power: 4/5 b/l, UL: Tone: cogwheel rigidity, Power: 4/5 b/l, Reflexes: 1+, Sensation: intact.Reflexes: 1+, Sensation: intact.
LL: Right/Left sided, Power 4+, Reflexes b/l LL: Right/Left sided, Power 4+, Reflexes b/l 1+, Sensation: intact1+, Sensation: intact
Gait ataxic,finger nose incoordination with Gait ataxic,finger nose incoordination with significant knee - heel incoordination.significant knee - heel incoordination. Romberg’s sign positive .. Planter reflex Romberg’s sign positive .. Planter reflex eqivocaleqivocal
CASE CASE SCENARIO SCENARIO
SECONDARY SECONDARY SURVEY SURVEY
? Intracranial pathology ? Intracranial pathology
? Parkinson disease ? Parkinson disease
? …? …
? …? …
CASE CASE SCENARIO SCENARIO
DIFFERENTIAL DIFFERENTIAL DIAGNOSIS DIAGNOSIS
What is your What is your NEXT STEPNEXT STEP ? ?
CASE CASE SCENARIO SCENARIO
WORK-UP WORK-UP
ECGECG
CASE CASE SCENARIO SCENARIO
WORK-UP WORK-UP
ECG: ECG: prolonged QTprolonged QT
CASE CASE SCENARIO SCENARIO
WORK-UP WORK-UP
QTcQTc
Normal QT = 340 - 430 ms Normal QT = 340 - 430 ms Pathological QT > 450 msPathological QT > 450 ms
ABGABGpH= 7.38pH= 7.38pCOpCO22= 39.4= 39.4pOpO22= 41.5= 41.5HCOHCO33= 22.8= 22.8
CASE CASE SCENARIO SCENARIO
INVESTIGATIONS INVESTIGATIONS
UE1UE1Na= 133Na= 133K= 4.8K= 4.8COCO22= 20= 20Urea= Urea= 14.114.1Cret= 222Cret= 222eGFR= 29eGFR= 29
BONEBONECaCa2+2+ = 2.4 = 2.4 albumin= albumin= 3838POPO44= 1.31= 1.31ALP= 180ALP= 180
CBCCBCHb = 11.2 Hb = 11.2 Plt= 232Plt= 232WBC= 8.8WBC= 8.8
CASE CASE SCENARIO SCENARIO
INVESTIGATIONS INVESTIGATIONS
BRAIN ATROPHYBRAIN ATROPHYCT BRAIN CT BRAIN
NEXT STEP ?NEXT STEP ?
CASE CASE SCENARIO SCENARIO
PROGRESS IN A/EPROGRESS IN A/E
HYDRATIONHYDRATION
Psychiatric medications:Psychiatric medications:LithiumLithium (Antimanic) (Antimanic)ChlorpromazineChlorpromazine (Antipsychotics) (Antipsychotics)
Differential diagnosis ?Differential diagnosis ?
Mediation:Mediation:Cavidelol , lisinopril, frusemide, aspirin, Cavidelol , lisinopril, frusemide, aspirin, simvastatin , insulin , psychiatry medicationssimvastatin , insulin , psychiatry medications
CASE CASE SCENARIO SCENARIO
MANAGEMENT in MANAGEMENT in A/E A/E
NEPHROLOGY CONSULTATION NEPHROLOGY CONSULTATION
LITHIUM LEVEL LITHIUM LEVEL 3.2 mEq/l3.2 mEq/l
PLASMA LITHIUM LEVELPLASMA LITHIUM LEVELTOXICITYTOXICITY
1.5 - 2.5 mEq/L1.5 - 2.5 mEq/LMildMild
2.5 - 3.5 mEq/L2.5 - 3.5 mEq/LModerateModerate
> 3.5 mEq/L> 3.5 mEq/LSeverecSeverec
Neuromuscular excitability, irregular coarse tremors, Neuromuscular excitability, irregular coarse tremors, fascicular twitching, rigid motor agitation, muscle fascicular twitching, rigid motor agitation, muscle weakness, ataxia, sluggishness, delirium, nausea, weakness, ataxia, sluggishness, delirium, nausea, vomiting, diarrhea, leukocytosis, sinus bradycardia, and vomiting, diarrhea, leukocytosis, sinus bradycardia, and hypotension. hypotension.
Can lead to seizures, stupor, coma, and a 10% risk of Can lead to seizures, stupor, coma, and a 10% risk of permanent neurologic sequelae (such as dementia and permanent neurologic sequelae (such as dementia and ataxia)ataxia)
NephrologyNephrology Impression: ARF secondary to Impression: ARF secondary to LITHIUM LITHIUM TOXICITYTOXICITY
CASE CASE SCENARIO SCENARIO
MEDICAL MEDICAL CONSULTATIONCONSULTATION
»»What are the indication of HD in this pt ?What are the indication of HD in this pt ?
» » Plan: Plan: HEMODIALYSISHEMODIALYSIS Lithium is the most dialyzable toxin Lithium is the most dialyzable toxin due to its: due to its: - low molecular weight- low molecular weight- negligible protein binding- negligible protein binding- volume of distribution similar to that - volume of distribution similar to that of waterof water
ADMISSION UNDER NEPHROLOGY TEAMADMISSION UNDER NEPHROLOGY TEAM
CASE CASE SCENARIO SCENARIO
DISPOSITION DISPOSITION
Indications of Indications of HemodialysisHemodialysisHDHD is indicated if one or more of the following is is indicated if one or more of the following is present: present:
- A plasma lithium level is >4 mEq/L, regardless of the - A plasma lithium level is >4 mEq/L, regardless of the clinical status of the patient.clinical status of the patient.
- A plasma lithium concentration >2.5 mEq/L in a - A plasma lithium concentration >2.5 mEq/L in a patient who is markedly symptomatic or who has renal patient who is markedly symptomatic or who has renal insufficiency or other conditions that can limit urinary insufficiency or other conditions that can limit urinary lithium excretion (such as congestive heart failure or lithium excretion (such as congestive heart failure or cirrhosis)cirrhosis)
- If the plasma lithium level is between 2.5 - 4 mEq/L in - If the plasma lithium level is between 2.5 - 4 mEq/L in an asymptomatic patient and is not anticipated to be an asymptomatic patient and is not anticipated to be less than 0.6 mEq/L within 36 hours. less than 0.6 mEq/L within 36 hours.
There is relatively slow equilibration between There is relatively slow equilibration between extracellular and intracellularextracellular and intracellular
As a result, there is a As a result, there is a rebound increaserebound increase in in plasma lithium levels after the cessation of plasma lithium levels after the cessation of dialysis as intracellular lithium diffuses into dialysis as intracellular lithium diffuses into the extracellular fluid. the extracellular fluid.
Recommend extending the duration of dialysis Recommend extending the duration of dialysis to 8-12 hrs to minimize rebound and to repeat to 8-12 hrs to minimize rebound and to repeat dialysis as necessary until the plasma dialysis as necessary until the plasma lithium level remains at less than 1 mEq/L for lithium level remains at less than 1 mEq/L for 6 to 8 hours after dialysis6 to 8 hours after dialysis
CASE CASE SCENARIO SCENARIO
FOLLOW-UP FOLLOW-UP
LITHIUM CLEARANCELITHIUM CLEARANCE
70 - 17070 - 170 ml/minml/min in hemodialysis in hemodialysis
10 - 40 ml/min10 - 40 ml/min in the urine in the urine (due to extensive proximal reabsorption) (due to extensive proximal reabsorption)
15 ml/min15 ml/min with peritoneal dialysis with peritoneal dialysis (because of the low blood flow associated with this (because of the low blood flow associated with this procedure) procedure)
CASE CASE SCENARIO SCENARIO
FOLLOW-UP FOLLOW-UP
Medications history Medications history
HemodialysisHemodialysis
......
CASE CASE SCENARIO SCENARIO
PITFALLS PITFALLS
Prolong QTProlong QT ? ?
Lithium toxicity Lithium toxicity hydration & hydration & hemodialysishemodialysis
PITFALLSPITFALLS TAKE HOME TAKE HOME MASSAGESMASSAGES